142 related articles for article (PubMed ID: 12975637)
1. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway.
Fernandez-Real JM; Broch M; Vendrell J; Ricart W
Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1552-6. PubMed ID: 12975637
[TBL] [Abstract][Full Text] [Related]
2. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.
Straczkowski M; Dzienis-Straczkowska S; Stêpieñ A; Kowalska I; Szelachowska M; Kinalska I
J Clin Endocrinol Metab; 2002 Oct; 87(10):4602-6. PubMed ID: 12364441
[TBL] [Abstract][Full Text] [Related]
3. Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study.
Fernandez-Real JM; Pugeat M; Grasa M; Broch M; Vendrell J; Brun J; Ricart W
J Clin Endocrinol Metab; 2002 Oct; 87(10):4686-90. PubMed ID: 12364459
[TBL] [Abstract][Full Text] [Related]
4. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.
González-Clemente JM; Mauricio D; Richart C; Broch M; Caixàs A; Megia A; Giménez-Palop O; Simón I; Martínez-Riquelme A; Giménez-Pérez G; Vendrell J
Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM
Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.
Straczkowski M; Kowalska I; Stepien A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I
Diabetes Care; 2002 Oct; 25(10):1824-8. PubMed ID: 12351485
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C
Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545
[TBL] [Abstract][Full Text] [Related]
8. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.
Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I
Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic white adults.
Ho RC; Davy KP; Hickey MS; Melby CL
Cytokine; 2005 Apr; 30(1):14-21. PubMed ID: 15784408
[TBL] [Abstract][Full Text] [Related]
10. Body fat changes and activity of tumor necrosis factor α system--a 5-year follow-up study.
Olszanecka-Glinianowicz M; Chudek J; Kocełak P; Szromek A; Zahorska-Markiewicz B
Metabolism; 2011 Apr; 60(4):531-6. PubMed ID: 20580040
[TBL] [Abstract][Full Text] [Related]
11. Novel interactions of adiponectin with the endocrine system and inflammatory parameters.
Fernández-Real JM; López-Bermejo A; Casamitjana R; Ricart W
J Clin Endocrinol Metab; 2003 Jun; 88(6):2714-8. PubMed ID: 12788878
[TBL] [Abstract][Full Text] [Related]
12. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects.
Fernández-Real JM; Gutiérrez C; Ricart W; Castiñeira MJ; Vendrell J; Richart C
Atherosclerosis; 1999 Oct; 146(2):321-7. PubMed ID: 10532687
[TBL] [Abstract][Full Text] [Related]
14. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus.
Fernandez-Real JM; Lainez B; Vendrell J; Rigla M; Castro A; Peñarroja G; Broch M; Pérez A; Richart C; Engel P; Ricart W
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E952-9. PubMed ID: 11882518
[TBL] [Abstract][Full Text] [Related]
15. Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects.
López-Bermejo A; Hernández-Aguado I; Vera IJ; Recasens M; Esteve E; Casamitjana R; Ricart W; Fernández-Real JM
Thromb Haemost; 2007 Feb; 97(2):240-4. PubMed ID: 17264953
[TBL] [Abstract][Full Text] [Related]
16. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab.
Di Rocco P; Manco M; Rosa G; Greco AV; Mingrone G
Obes Res; 2004 Apr; 12(4):734-9. PubMed ID: 15090644
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects.
Corica F; Allegra A; Corsonello A; Buemi M; Calapai G; Ruello A; Nicita Mauro V; Ceruso D
Int J Obes Relat Metab Disord; 1999 Apr; 23(4):355-60. PubMed ID: 10340812
[TBL] [Abstract][Full Text] [Related]
18. Plasma soluble tumor necrosis factor-alpha receptors circulate in proportion to leptin levels during the menstrual cycle in lean but not in obese women.
Fernández-Real JM; Gutierrez C; Vendrell J; Casamitjana R; Ricart W
Eur J Endocrinol; 2000 Aug; 143(2):235-41. PubMed ID: 10913943
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass.
Molina A; Vendrell J; Gutiérrez C; Simón I; Masdevall C; Soler J; Gómez JM
Obes Surg; 2003 Aug; 13(4):615-21. PubMed ID: 12935365
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients.
Fernández-Real JM; Vendrell J; Ricart W; Broch M; Gutiérrez C; Casamitjana R; Oriola J; Richart C
Diabetes Care; 2000 Jun; 23(6):831-7. PubMed ID: 10841005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]